SG11201910191RA - A peptide capable of forming a gel for use in tissue engineering and bioprinting - Google Patents
A peptide capable of forming a gel for use in tissue engineering and bioprintingInfo
- Publication number
- SG11201910191RA SG11201910191RA SG11201910191RA SG11201910191RA SG 11201910191R A SG11201910191R A SG 11201910191RA SG 11201910191R A SG11201910191R A SG 11201910191RA SG 11201910191R A SG11201910191R A SG 11201910191RA
- Authority
- SG
- Singapore
- Prior art keywords
- gel
- present
- international
- peptide
- science
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1 Cr) O N O 00 1-1 O C (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 15 November 2018 (15.11.2018) WIPO I PCT Hu omit °nolo oi mom oimIE (10) International Publication Number WO 2018/207036 Al (51) International Patent Classification: C07K 5/11 (2006.01) A61L 27/38 (2006.01) CO7K 5/103 (2006.01) A61L 27/50 (2006.01) CO7K 5/113 (2006.01) A61L 27/52 (2006.01) CO7K 5/107 (2006.01) A61L 27/54 (2006.01) A61K 38/07 (2006.01) (21) International Application Number: PCT/IB2018/052173 (22) International Filing Date: 29 March 2018 (29.03.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/504,976 11 May 2017 (11.05.2017) US (71) Applicant: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY [SA/SA]; 4700 King Abdullah University of Science and Technology, Thuwal, 23955-6900 (SA). (72) Inventor: HAUSER, Charlotte, A.E.; King Abdullah Uni- versity of Science and Technology, Division of Biologi- cal & Environmental Science & Engineering, Laboratory for Nanomedicine, Al-Haytham Building (Bldg. 2), Office 4217, Thuwal, 23955-6900 (SA). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (54) Title: A PEPTIDE CAPABLE OF FORMING A GEL FOR USE IN TISSUE ENGINEERING AND BIOPRINTING Figure 1 A Add Water to Peptide ) 900 uf Wdter mr .\" Vortex lip irt Add 10x PBS (1:10) lox (57) : The present invention relates to peptides capable of forming a gel and to their use in tissue engineering and bioprinting. The present invention furthermore relates to a gel comprising a peptide in accordance with the present invention, to a method of preparing such gel and to the use of such gel. In one embodiment, such gel is a hydrogel. The present invention furthermore relates to a wound dressing or wound healing agent comprising a gel according to the present invention and to a surgical implant or stent comprising a peptide scaffold formed by a gel according to the present invention. Moreover, the present invention also relates to a pharmaceutical and/or cosmetic composition, to a biomedical device or an electronic device comprising the peptide according to the present invention. [Continued on next page] WO 2018/207036 Al IIIIIIIIIIIIIIIIIIIIIIDEIIIIIIIH IIIIII0101IIIIIIIIIIIIIIIIIIIIIIIIIIIIIII VOIMIE SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a))
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762504976P | 2017-05-11 | 2017-05-11 | |
PCT/IB2018/052173 WO2018207036A1 (en) | 2017-05-11 | 2018-03-29 | A peptide capable of forming a gel for use in tissue engineering and bioprinting |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201910191RA true SG11201910191RA (en) | 2019-11-28 |
Family
ID=62025900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201910191R SG11201910191RA (en) | 2017-05-11 | 2018-03-29 | A peptide capable of forming a gel for use in tissue engineering and bioprinting |
Country Status (7)
Country | Link |
---|---|
US (1) | US11472839B2 (en) |
EP (1) | EP3621978A1 (en) |
JP (1) | JP7326161B2 (en) |
KR (1) | KR102611274B1 (en) |
SA (1) | SA519410522B1 (en) |
SG (1) | SG11201910191RA (en) |
WO (1) | WO2018207036A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3181424A1 (en) | 2012-03-09 | 2013-09-12 | Vestaron Corporation | Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides |
US11692016B2 (en) | 2012-03-09 | 2023-07-04 | Vestaron Corporation | High gene expression yeast strain |
EP3528617A4 (en) * | 2016-10-21 | 2020-11-25 | Vestaron Corporation | Cleavable peptides and insecticidal and nematicidal proteins comprising same |
EP4215600A1 (en) | 2017-05-11 | 2023-07-26 | King Abdullah University of Science and Technology | Device and method for microfluidics-based 3d bioprinting |
WO2018207036A1 (en) | 2017-05-11 | 2018-11-15 | King Abdullah University Of Science And Technology | A peptide capable of forming a gel for use in tissue engineering and bioprinting |
EP3993765A4 (en) * | 2019-07-05 | 2023-08-09 | Regenics AS | Wound debridement systems |
WO2021070083A1 (en) * | 2019-10-07 | 2021-04-15 | King Abdullah University Of Science And Technology | Biomaterial composite, peptide-based adhesives and methods of use thereof |
US20220054706A1 (en) * | 2020-08-20 | 2022-02-24 | King Abdullah University Of Science And Technology | Scaffolds from self-assembling tetrapeptides support 3d spreading, osteogenic differentiation and angiogenesis of mesenchymal stem cells |
WO2022038553A1 (en) * | 2020-08-20 | 2022-02-24 | King Adbullah University Of Science And Technology | 3d neuronal tissue grafts using ultrashort self-assembling peptide scaffolds |
US11673324B2 (en) | 2020-08-20 | 2023-06-13 | King Abdullah University Of Science And Technology | Nozzle for 3D bioprinting |
US20220056074A1 (en) * | 2020-08-20 | 2022-02-24 | King Abdullah University Of Science And Technology | Peptide compound with repetitive sequences |
US20230279344A1 (en) * | 2020-09-02 | 2023-09-07 | King Abdullah University Of Science And Technology | Air-loaded gas vesicle nanoparticles for promoting cell growth in 3d bioprinted tissue constructs |
EP4208471A1 (en) * | 2020-09-02 | 2023-07-12 | King Abdullah University Of Science And Technology | Peptide-based dopa containing adhesive gels |
KR102486996B1 (en) * | 2020-09-04 | 2023-01-10 | 서울대학교병원 | Peptide and composition for improving wrinkle and treating metabolic desease containing the same |
US20230382948A1 (en) * | 2020-10-21 | 2023-11-30 | King Abdullah University Of Science And Technology | Delivery of endothelial cell-laden microgel elicits angiogenesis in self-assembling ultrashort peptide hydrogels |
WO2022254394A1 (en) * | 2021-06-04 | 2022-12-08 | King Adbullah University Of Science And Technology | Method of stopping bleeding using nanofibrous peptide hydrogels as hemostasis agent |
WO2022254312A1 (en) * | 2021-06-04 | 2022-12-08 | King Adbullah University Of Science And Technology | Self-assembling nanofibrous ultrashort peptide hydrogels for vascular tissue engineering |
CN113321706B (en) * | 2021-07-15 | 2022-01-07 | 南开大学 | Self-assembly polypeptide derivative and hydrogel prepared from same |
WO2023196852A1 (en) * | 2022-04-06 | 2023-10-12 | 3-D Matrix, Ltd. | Jammed gel bioink with self-assembling peptides |
US20230323305A1 (en) * | 2022-04-06 | 2023-10-12 | 3-D Matrix, Ltd. | Bioink containing self-assembling peptides |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2109054A1 (en) | 2008-04-09 | 2009-10-14 | Biotempt B.V. | Methods for identifying biologically active peptides and predicting their function |
EP2407479B2 (en) | 2009-03-09 | 2017-08-23 | Menicon Co., Ltd. | Self-assembling peptide and peptide gel with high strength |
JP5833096B2 (en) | 2010-03-31 | 2015-12-16 | エイジェンシー フォー サイエンス, テクノロジー アンド リサーチAgency For Science,Technology And Research | Amphiphilic linear peptide / peptoid and hydrogel containing the same |
JP5945802B2 (en) | 2011-05-31 | 2016-07-05 | 国立大学法人 千葉大学 | Complex hepatocyte tissue body and method for producing the same |
EP2773696B1 (en) | 2011-11-04 | 2017-07-26 | Agency For Science, Technology And Research | Self-assembled composite ultrasmall peptide-polymer hydrogels |
ES2702033T3 (en) | 2011-11-21 | 2019-02-27 | Abay Sa | Signal amplification in immunoassays |
SG193042A1 (en) | 2012-02-22 | 2013-09-30 | Agency Science Tech & Res | Organogels from ultrasmall peptides that can be used for biological and non-biological applications |
SG2012096699A (en) | 2012-12-31 | 2014-07-30 | Agency Science Tech & Res | Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
JP6857857B2 (en) | 2013-04-30 | 2021-04-14 | 国立大学法人九州工業大学 | Peptides and their self-assembly methods, their aggregates, cell culture substrates using them, and methods for producing cell sheets. |
KR20160013068A (en) | 2013-05-15 | 2016-02-03 | 토비라 쎄라퓨틱스, 인크. | Cenicriviroc compositions and methods of making and using the same |
CN105579219B (en) | 2013-06-13 | 2017-09-01 | 安斯百克特生物***公司 | System and method for the increasing material manufacturing of three-dimensional structure |
US11903612B2 (en) | 2013-11-04 | 2024-02-20 | University Of Iowa Research Foundation | Bioprinter and methods of using same |
US20170002041A1 (en) | 2013-11-30 | 2017-01-05 | Agency For Science, Technology And Research | Novel ultrashort hydrophobic peptides that self-assemble into nanofibrous hydrogels and their uses |
WO2015080671A1 (en) * | 2013-11-30 | 2015-06-04 | Agency For Science, Technology And Research | Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing |
JP2016079190A (en) | 2014-10-09 | 2016-05-16 | Dic株式会社 | Curing device |
JP6937696B2 (en) * | 2015-02-06 | 2021-09-22 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | Tissue engineering type tissue substitution system |
CN107406487A (en) | 2015-03-06 | 2017-11-28 | 新加坡科技研究局 | The ultrashort aliphatic depsipeptides of self assembly for biomedical applications |
WO2017089963A1 (en) | 2015-11-23 | 2017-06-01 | King Abdullah University Of Science And Technology | Methods of making microfluidic devices |
US11118210B2 (en) | 2016-07-28 | 2021-09-14 | California Institute Of Technology | Genetically engineered gas vesicle gene clusters, genetic circuits, vectors, prokaryotic cells, compositions, methods and systems for contrast-enhanced imaging |
JP6172776B1 (en) | 2016-07-29 | 2017-08-02 | Necソリューションイノベータ株式会社 | Inventory management system, inventory management method, program, and recording medium |
AU2017371444A1 (en) | 2016-12-09 | 2019-06-20 | Biogelx Limited | 3D printing and drug delivery |
EP4215600A1 (en) | 2017-05-11 | 2023-07-26 | King Abdullah University of Science and Technology | Device and method for microfluidics-based 3d bioprinting |
WO2018207036A1 (en) | 2017-05-11 | 2018-11-15 | King Abdullah University Of Science And Technology | A peptide capable of forming a gel for use in tissue engineering and bioprinting |
FR3069806B1 (en) | 2017-08-03 | 2019-08-23 | Centre National De La Recherche Scientifique | PRINTER HEAD OF PRINTER, PRINTER, AND PRINTING METHOD |
US20210114276A1 (en) | 2018-06-13 | 2021-04-22 | University Of Washington | Extruded hydrogel tubes and coaxial fibers and applications thereof |
WO2020162835A1 (en) | 2019-02-08 | 2020-08-13 | Agency For Science, Technology And Research | A self-assembling short amphiphilic peptide and related methods and uses |
CN111172100B (en) | 2019-12-31 | 2021-08-31 | 浙江大学 | Biological 3D printing method for controlling cell orientation arrangement |
-
2018
- 2018-03-29 WO PCT/IB2018/052173 patent/WO2018207036A1/en unknown
- 2018-03-29 SG SG11201910191R patent/SG11201910191RA/en unknown
- 2018-03-29 EP EP18718922.0A patent/EP3621978A1/en active Pending
- 2018-03-29 US US16/612,881 patent/US11472839B2/en active Active
- 2018-03-29 JP JP2019561848A patent/JP7326161B2/en active Active
- 2018-03-29 KR KR1020197036272A patent/KR102611274B1/en active IP Right Grant
-
2019
- 2019-11-10 SA SA519410522A patent/SA519410522B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP7326161B2 (en) | 2023-08-15 |
EP3621978A1 (en) | 2020-03-18 |
KR102611274B1 (en) | 2023-12-07 |
US20200148720A1 (en) | 2020-05-14 |
WO2018207036A1 (en) | 2018-11-15 |
JP2020519605A (en) | 2020-07-02 |
US11472839B2 (en) | 2022-10-18 |
SA519410522B1 (en) | 2023-01-29 |
KR20200006995A (en) | 2020-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201910191RA (en) | A peptide capable of forming a gel for use in tissue engineering and bioprinting | |
SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
SG11201806340YA (en) | Zika virus vaccine | |
SG11201901390TA (en) | Tetracycline compounds and methods of treatment | |
SG11201908740VA (en) | Sustained release delivery systems comprising traceless linkers | |
SG11201809064QA (en) | Chimeric neurotoxins | |
SG11201908971RA (en) | Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene | |
SG11201907673YA (en) | Pharmaceutical compositions for combination therapy | |
SG11201810117WA (en) | Human platelet lysate derived extracellular vesicles for use in medicine | |
SG11201908420WA (en) | Compositions of plinabulin and use thereof | |
SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
SG11201901494UA (en) | Acid-alpha glucosidase variants and uses thereof | |
SG11201906041QA (en) | Pharmaceutical compositions for combination therapy | |
SG11201811442UA (en) | Formulation of a peptide vaccine | |
SG11201906959RA (en) | Aryl hydrocarbon receptor (ahr) modulator compounds | |
SG11201908060PA (en) | Wound healing medicament | |
SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
SG11201809341PA (en) | Mobile robot | |
SG11201810078PA (en) | Stabilized pre-fusion rsv f proteins | |
SG11201903312VA (en) | Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine | |
SG11201811345TA (en) | Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections | |
SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases |